Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT00471081

Completed

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Infections, Meningococcal
NCT01565135

Completed

Immunization Delivery in Obstetrics and Gynecology Settings

Immunization Status Among Obstetrics and Gynecology Patients
NCT02456077

Completed

Strengthening Physician Communication About HPV Vaccines

HPV Immunization Status
NCT03851978

Completed

Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain

Pneumococcal Pneumonia
NCT03473002

Completed

A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults

Respiratory Syncytial Virus Infection | Antiviral Prophylaxis
NCT02893878

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

Influenza, Human
NCT03085381

Completed

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

HPV Infections
NCT03150537

Completed

Comparison of Routine IM Influenza Immunization and Administration by Jet-injector (Med-Jet H4™) in Healthy Young Adults (Med-Jet H4™)

Needle Phobia
NCT01841918

Completed

Safety and Immunogenicity of Live Attenuated Influenza H5N2

Influenza Due to Influenza A Virus Subtype H5N2
NCT01239537

Completed

Swine Flu (Influenza A H1N1) Follow on Vaccine Study

Influenza
NCT01641042

Completed

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Infections, Meningococcal
NCT02692859

Completed

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus Influenza
NCT02145234

Completed

Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects

Healthy Adults
NCT03212911

Unknown

HBV Vaccination in HIV-infected Adults

Hepatitis B Vaccination, HIV
NCT01077531

Terminated

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Arthritis, Rheumatoid
NCT02917304

Completed

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

Influenza, Human
NCT00264576

Completed

Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults

Influenza Disease; Flu
NCT02118766

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic
NCT00376779

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b
NCT00197158

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B
NCT00136331

Completed

Study of a Pandemic Influenza Vaccine

Influenza
NCT01152814

Completed

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

Seasonal Influenza
NCT01602367

Terminated

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

Hypertension
NCT01361555

Terminated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Depression
NCT01650324

Completed

A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects

Diabetes Mellitus, Type 2
NCT01906190

Completed

Persistence of Immune Response After Vaccination With Influenza Vaccine

Influenza, Human | Immunisation Reaction
NCT01304810

Completed

A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

Smoking Cessation | Nicotine Dependence
NCT01178346

Completed

Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

Smoking Cessation
NCT01254955

Completed

Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients

Organ Transplantation
NCT01357265

Completed

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

Influenza
NCT00828022

Unknown

Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer (SMC4692)

Measles | Non-Small Cell Lung Cancer
NCT00144313

Completed

VaxTeen Hepatitis B Vaccine Booster Study

Hepatitis
NCT00430534

Completed

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Epstein Barr Virus (EBV) Infection
NCT00423566

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Tuberculosis
NCT00052130

Unknown

Vaccine Therapy for Patients With Stage III Melanoma

Malignant Melanoma
NCT00052156

Unknown

Vaccine Therapy for Patients With Stage IV Melanoma

Malignant Melanoma
NCT06891872

Not yet recruiting

Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine

DTaP Vaccine | MMR Vaccine | Varicella (chickenpox)
NCT05035680

Withdrawn

Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion

Influenza
NCT01246999

Completed

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Influenza
NCT01346592

Completed

Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age

Influenza Disease
NCT07135427

Recruiting

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency (IgG in AATD)

COPD | Antibody Deficiency | Alpha 1-Antitrypsin
NCT05862337

Recruiting

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Hepatocellular Carcinoma
NCT05291845

Recruiting

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Warts | Human Papilloma Virus
NCT03971669

Recruiting

Blood Donor CVD 5000

Risk Reduction
NCT06622109

Active, not recruiting

A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months

Pneumococcal Disease
NCT06793826

Completed

Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

Hepatitis B | Haemophilus Influenzae Type b Immunisation
NCT03152903

Completed

Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence

Prevention of TB Recurrence
NCT01926860

Completed

PCV13 + Hepatitis a Vaccine for Adults (PCV13+HepA)

Measurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis a
NCT05329259

Completed

A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India

Pneumococcal Disease
NCT00820846

Completed

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

HIV Infections

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations